126
Participants
Start Date
March 31, 2006
Primary Completion Date
June 30, 2012
Study Completion Date
June 30, 2012
Everolimus (RAD001)
Cyclosporine (Calcineurin Inhibitor (CNI))
Methylprednisone/prednisone
Mycophenolate sodium (MPA)
Royal Prince Alfred Hospital, NSW
Westmead Hospital, NSW
Princess Alexandra Hospital, QLD
Monash Medical Centre, Sale
Queen Elizabeth Hospital, Sale
Royal Melbourne Hospital, VIC
Sir Charles Gairdner Hospital, WA
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY